
Walter Curran
Professor Emeritus · Emory University School of Medicine
Credentials: · · ·
History
- 1983–1987
Radiation Oncology
- 1982–1983
Preliminary or Transitional Year
- 1978–1982
Research
Lung cancer: current therapies and new targeted treatments
Review · The Lancet · 2017 · 2,726 citations
A randomized trial of bevacizumab for newly diagnosed glioblastoma
New England Journal of Medicine · 2014 · 2,221 citations
The Lancet · 2004 · Last of 14 authors · 1,832 citations

46 papers

43 papers

43 papers

40 papers

36 papers · 36 as a resident

34 papers

33 papers

31 papers
Grants
- 2014–2025
NRG Oncology Network Group Operations Center
National Cancer Institute · U10
PI · $106.7M · Nrg Oncology Foundation, Inc.
- 2009–2023
Winship Cancer Institute Cancer Center Support Grant
National Cancer Institute · P30
Contact PI · $23.5M · Emory University
- 2005–2015
National Cancer Institute · U24
Contact PI · $9M · American College of Radiology
- 1979–2014
Radiation Therapy Oncology Group
National Cancer Institute · U10
Contact PI · $203.7M · American College of Radiology
Clinical trials
- 1990–2002
Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
Principal investigator · Completed · Phase 3
Radiation Therapy Oncology Group
- 1994–2012
Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Study chair · Completed · Phase 3
Radiation Therapy Oncology Group


